Scalper1 News
Valeant Pharmaceuticals International (VRX) raised its bid for fellow specialty drugmaker Allergan (AGN) again on Friday, but made its offer contingent on “good faith negotiations,” in contrast to its previous hostile bids. Allergan’s stock trading was halted mid-afternoon as Valeant rolled out its latest proposal, which lifted the cash-per-share offer to $72 from $58.30, while retaining Valeant’s stock offering of 0.83 share for each Allergan Scalper1 News
Scalper1 News